Company intelligence / Profile preview

Reference Medicine

Ownership: Private
Development stage: Commercial

Overview

Reference Medicine provides high-quality oncology biospecimens to support cancer diagnostic development and research. They source globally from IRB/EC-accredited institutions with rigorous quality control at both histological and molecular levels. Their inventory supports rapid access for researchers developing diagnostics or conducting translational studies in oncology. The company does not conduct clinical trials or have clinical results as it supplies research materials rather than therapies.

Therapeutic areas: Oncology
Modalities: Human tissue specimens (FFPE blocks, slides)plasmamatched tumor tissue and plasma
Industry: Chemicals & Materials

Partnerships

IRB/EC-accredited hospitals and pathology groups worldwide (for specimen sourcing)

Beyond the preview

Go deeper on Reference Medicine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reference Medicine.

Explore the full profile